Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair-deficient/microsatellite instability-high endometrial cancer treated with dostarlimab

OBJECTIVE: There is an increase in patient-reported outcome assessments to gain information on new drug candidates from the patient’s perspective. A data gap remains in patient-reported outcome measurements for anti-programmed death 1 (anti-PD-1) therapies in endometrial cancer. We present patient-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristeleit, Rebecca, Mathews, Cara, Redondo, Andres, Boklage, Susan, Hanlon, Jennifer, Im, Ellie, Brown, Jubilee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554028/
https://www.ncbi.nlm.nih.gov/pubmed/35973737
http://dx.doi.org/10.1136/ijgc-2022-003492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554028/
https://www.ncbi.nlm.nih.gov/pubmed/35973737
http://dx.doi.org/10.1136/ijgc-2022-003492

Ejemplares similares